Baroda Clinical Laboratory Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 9 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 5.23 M
About Baroda Clinical Laboratory
Baroda Clinical Laboratory Private Limited (BCLPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 April 2008 and has a history of 16 years and nine months. Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.23 M.
Ravindra Pasale and Sujat Paneri serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U33125GJ2008PTC053691
-
Company No.
053691
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Apr 2008
-
Date of AGM
30 Sep 2016
-
Date of Balance Sheet
31 Mar 2016
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Baroda Clinical Laboratory?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravindra Pasale
|
Director | 25-Apr-2008 | Current |
|
Sujat Paneri
|
Director | 30-Sep-2016 | Current |
Financial Performance of Baroda Clinical Laboratory.
Enhance accessibility to Baroda Clinical Laboratory's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Baroda Clinical Laboratory?
In 2016, Baroda Clinical Laboratory had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹5.23 M
₹0
Charges Breakdown by Lending Institutions
- The Baroda City Co-Operative Bank Ltd : 0.28 Cr
- State Bank Of India : 0.24 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Dec 2012 | The Baroda City Co-Operative Bank Ltd | ₹2.30 M | Open |
| 07 Nov 2012 | The Baroda City Co-Operative Bank Ltd | ₹0.50 M | Open |
| 20 Mar 2009 | State Bank Of India | ₹2.43 M | Open |
How Many Employees Work at Baroda Clinical Laboratory?
Unlock and access historical data on people associated with Baroda Clinical Laboratory, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Baroda Clinical Laboratory, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Baroda Clinical Laboratory's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
